Johns Hopkins Drug Access and Affordability Initiative
JHDAAI develops bipartisan policy recommendations to increase the affordability of pharmaceuticals in the US.
About the Johns Hopkins Drug Access and Affordability Initiative
JHDAAI develops bipartisan policy recommendations to increase the affordability of pharmaceuticals in the U.S.
The challenge is balancing the need for innovation, the need to improve patients’ access to medications, and the need to reduce overall medical costs in our health care system.
We invite policymakers, researchers, and the public to explore our work and take advantage of our resources to improve pharmaceutical access.
New and Noteworthy
A year on, the national shortage of Adderall persists
NPR’s Ayesha Rascoe talks with JHDAAI’s Mariana Socal of Johns Hopkins about the continuing shortage of ADHD medications.
State drug pricing boards tee up new front in pharma legal fight
Gerard Anderson weighs in on a wave of state boards aiming to set limits on what health plans pay for prescription drugs.